ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014

In Brief: Most NCI Grants, Including Noncompeting And r01s, Will Take Cuts Of At Least 4 Percent; Paylines Set

January 22, 1982

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994

Will Insurers Pay Patient Care Costs? Stay Tuned For Act II Of This Oncodrama

July 31, 1998

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

April 26, 2002

St. Martin’s Press Buys Rights To Book By Brawley, Goldberg.

March 12, 2010